Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

May 2013
Scientific News
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
08 May 2013 - 10 May 2013
Boston, MA, Hyatt Regency
Drug Discovery Summit
More information
3rd Serialization and Traceability for Brand Protection
09 May 2013 - 10 May 2013
Philadelphia, PA, USA
3rd Serialization and Traceability for Brand Protection
More information
14 May 2013 - 15 May 2013
London UK
Stability Testing in Pharmaceutical Development and Manufacturing
More information
14 May 2013 - 15 May 2013
London, UK
Stability Testing in Pharmaceutical Development and Manufacturing
More information
2nd Annual Open Innovation in Pharmaceutical R&D
15 May 2013 - 16 May 2013
Amsterdam, Netherlands
2nd Annual Open Innovation in Pharmaceutical R&D
More information
Pain Therapeutics
20 May 2013 - 21 May 2013
London, UK
Pain Therapeutics
More information
21 May 2013 - 27 Jun 2013
Live-on-the-Web
LC/MS Fundamentals and Applications
More information
22 May 2013 - 22 May 2013
Webinar via WebEx
Webinar: Managing Change - Ensuring Lab Informatics Solution Adoption
More information
29 May 2013 - 31 May 2013
Sofia, Bulgaria
9th SEE Congress & Exhibition on Energy Efficiency & Renewable Energy (EE & RE)
More information
<< 1 2 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!